Japanese scientists have discovered a naturally-occurring bacteria in a frog species with remarkably-potent anticancer activity — in fact, it destroyed cancer tumors in one dose. Led by Professor Eijiro Miyako, the team at Japan’s Advanced Institute of Science and Technology discovered that a natural bacteria from the intestines of a Japanese tree frog achieved a 100% tumor elimination rate in mice with just a single intravenous dose. Not only did the gut bacteria kill the cancer cells, it also engaged the animal’s immune system for comprehensive tumor destruction. The research team isolated a total of 45 bacterial strains from the intestines of Japanese tree frogs, fire belly newts, and grass lizards. Through systematic screening, nine strains demonstrated anti-tumor effects, with E. americana exhibiting the most exceptional therapeutic efficacy. In mice with colorectal cancer, a single intravenous administration of E. americana achieved complete tumor elimination with a 100% complete response rate — dramatically surpassing the efficacy of current standard therapies. Future research and development will expand to other cancer types, evaluating the efficacy in breast cancer, pancreatic cancer, melanoma, and other malignancies.
Japanese Team Finds Frog Bacteria That Wipes Out Cancer Tumors With a Single Dose
Japanese scientists have discovered a naturally-occurring bacteria in a frog species with remarkably-potent anticancer activity — in fact, it destroyed cancer tumors in one dose. Led by Professor Eijiro Miyako, the team at Japan’s Advanced Institute of Science and Technology discovered that a natural bacteria from the intestines of a Japanese tree frog achieved a 100% tumor elimination rate in mice with just a single intravenous dose. Not only did the gut bacteria kill the cancer cells, it also engaged the animal’s immune system for comprehensive tumor destruction. The research team isolated a total of 45 bacterial strains from the intestines of Japanese tree frogs, fire belly newts, and grass lizards. Through systematic screening, nine strains demonstrated anti-tumor effects, with E. americana exhibiting the most exceptional therapeutic efficacy. In mice with colorectal cancer, a single intravenous administration of E. americana achieved complete tumor elimination with a 100% complete response rate — dramatically surpassing the efficacy of current standard therapies. Future research and development will expand to other cancer types, evaluating the efficacy in breast cancer, pancreatic cancer, melanoma, and other malignancies.
